Ladenburg Thalmann analyst Aydin Huseynov initiated coverage of Adverum Biotechnologies with a Buy rating and $2 price target.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ADVM:
- Adverum Biotechnologies to Present at Upcoming Investor Conferences
- Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Questions or Comments about the article? Write to editor@tipranks.com